MANAGEMENT OF TYPE 2 DIABETES IN DEVELOPING COUNTRIES: BALANCING OPTIMAL GLYCAEMIC CONTROL AND OUTCOMES WITH AFFORDABILITY AND ACCESSIBILITY TO TREATMENT